Evidence map›Paper›PMID 20111037›Full record

ReviewNature methods2010

Target-enrichment strategies for next-generation sequencing.

Lira Mamanova, Alison J Coffey, Carol E Scott, Iwanka Kozarewa, Emily H Turner, Akash Kumar, Eleanor Howard, Jay Shendure, Daniel J Turner

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature methods, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03084224 (Implementation of Molecular Diagnostic Pathways in Neurological and Neurodegenerative Diseases), which is not on this map. Cited by 529 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
529citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03084224 unknown statusnot on this mapstarted 2019, after this paper: background citation

Implementation of Molecular Diagnostic Pathways in Neurological and Neurodegenerative Diseases

Typeobservational_patient_registrySponsorNeuromed IRCCSRan2019 to 2025Enrolled1ConditionsGenetic DiseaseArmsneurological and neurodegenerative diseases
3 · Its place in the literature

Who cites it

529 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. A Noninvasive Circulating Tumor DNA Methylation Classifier to Identify Benign Pulmonary Nodules.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Integrating metagenomics and metatranscriptomics intoThe Journal of general virology · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Genome writing and Targeted Delivery of thebioRxiv : the preprint server for biology · 2026
    Article

469 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lira MamanovaThe Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Alison J Coffey
Carol E Scott
Iwanka Kozarewa
Emily H Turner
Akash Kumar
Eleanor Howard
Jay Shendure
Daniel J Turner

Funding

SeattleSeqR01HL094976 · NHLBI · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN, GREEN, PHILIP P · 2008 to 2009
$4.0M
Molecular Tools for Genome PartitioningR21HG004749 · NHGRI · UNIVERSITY OF WASHINGTON · PI SHENDURE, JAY ASHOK · 2008 to 2009
$405k
NHGRI NIH HHS 5R21HG004749NHGRI NIH HHS R21 HG004749NHLBI NIH HHS 5R01HL094976Wellcome Trust WT079643
6 · The paper itself

Abstract

We have not yet reached a point at which routine sequencing of large numbers of whole eukaryotic genomes is feasible, and so it is often necessary to select genomic regions of interest and to enrich these regions before sequencing. There are several enrichment approaches, each with unique advantages and disadvantages. Here we describe our experiences with the leading target-enrichment technologies, the optimizations that we have performed and typical results that can be obtained using each. We also provide detailed protocols for each technology so that end users can find the best compromise between sensitivity, specificity and uniformity for their particular project.

Indexed as

ForecastingChromosome MappingGene TargetingIn Situ HybridizationMolecular Probe TechniquesPolymerase Chain ReactionSequence Analysis, DNA

Identifiers

PMID20111037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.